KR900016238A - 신규 화합물 - Google Patents

신규 화합물 Download PDF

Info

Publication number
KR900016238A
KR900016238A KR1019900005135A KR900005135A KR900016238A KR 900016238 A KR900016238 A KR 900016238A KR 1019900005135 A KR1019900005135 A KR 1019900005135A KR 900005135 A KR900005135 A KR 900005135A KR 900016238 A KR900016238 A KR 900016238A
Authority
KR
South Korea
Prior art keywords
leucine
hydrogen
compound
phosphonopropyl
amino
Prior art date
Application number
KR1019900005135A
Other languages
English (en)
Inventor
에드워드 마아크웰 로저
윌리엄 워드 로버트
제임즈 헌터 데이빗
Original Assignee
원본미기재
비이참 그루우프 피이엘시이
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB898908353A external-priority patent/GB8908353D0/en
Priority claimed from GB898917756A external-priority patent/GB8917756D0/en
Application filed by 원본미기재, 비이참 그루우프 피이엘시이 filed Critical 원본미기재
Publication of KR900016238A publication Critical patent/KR900016238A/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/5532—Seven-(or more) membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
    • C07F9/40—Esters thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
    • C07F9/3804—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se) not used, see subgroups
    • C07F9/3808—Acyclic saturated acids which can have further substituents on alkyl
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids RP(=O)(OH)2; Thiophosphonic acids, i.e. RP(=X)(XH)2 (X = S, Se)
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/572—Five-membered rings
    • C07F9/5728—Five-membered rings condensed with carbocyclic rings or carbocyclic ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0827—Tripeptides containing heteroatoms different from O, S, or N

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

내용 없음.

Description

신규 화합물
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (16)

  1. 일반식(Ⅰ)의 화합물 또는 그들의 염, 용매화합물 또는 수화물 :
    (여기에서 R은 수소, C1-6알킬 또는 임의적으로 치환된 벤질; R1은 수소 또는 C1-6알킬 : R2는 C3-6알킬 R3는 수소, 알킬, Z이 임의적으로치환된 페닐 또는 헤테로아릴인 -CH2-Z, 또는 R7이 수소, 알킬 또는 -CH2-Ph(여기서 Ph는 임의적으로 치환된 페닐임)이고 R8이 수소 또는 알킬기 기및 R4는 n은 1 내지 6의 정수이고, R5,R6및 R9가 수소 또는 C1-6알킬; R10은 히드록시 또는 -O-C1-6알킬 또는 -NR5R6(여기에서 R5및 R6은 연결되어 헤테로시클릭 고리를 형성할 수도 있다)인 -CH2-(CH2)nOR5또는 -CH2-(CH)nOCOR6또는이고 또는 R3및 R4는 m이 4 내지 12의 정수인 -(CH2)m-로서 함께 결합될 수 있다)
  2. 제1항에 있어서, R이 수소, 메틸 또는 에틸인 화합물.
  3. 제1항 또는 제2항에 있어서, R1이 수소, 메틸, 에틸, 이소프로필 또는 n-부틸인 화합물.
  4. 제1항 내지 제3항 중 어느 한 항에 있어서, R2가 n-부틸, 이소부틸 또는 섹크-부틸인 화합물.
  5. 제1항 내지 제4항중 어느 한 항에 있어서, R3가 벤질, 4-히드록시벤질, 4-메톡시벤질 또는 3-인돌일메틸이고, R4가 -(CH2)2OH, -(CH2)2OCH3또는 -CH(CH3)CO2CH3거나, R3및 R4가 m이 10인 -(CH2)m으로서 결합되는 화합물.
  6. 제1항 내지 제5항중 어느 한 항에 있어서, R이 수소 또는 에틸이고, R은 메틸, 에틸 또는 n-부틸이고; R2는 이소-부틸이고, R3는 4-메톡시 벤질 또는 3-인돌일 메틸이고 R4는 -(CH2)2OH 또는 -CH(CH3)CO2CH3이거나; R3및 R4가 함께 m이 10인 -(CH2)m인 화합물.
  7. 제1항 내지 제6항중 어느 한 항에 있어서, 일반식(Ⅰ)에서 별표로 표시된 키탈 중심이 R3가 수소가 아닐 때 S- 배치를 갖는 화합물.
  8. N-[N-[N-(1-포스포노에틸)-류실]-(S)-트리프토필]-(S)-알라닌, 메틸 에스터,N-[N-[N-(1-포스포노에틸)-류실]-Q-메틸-(S)-티로실]-(S)-알라닌, 메틸 에스터, 3-[N-[N-((S)-1-포스포노프로필)-(R)-류실]]-아미노-아자시클로트리데칸-2-온, 3-[N-[N-((S)-1-포스포노프로필)-(S)-류실]]-(-)-아미노-아자시클로트리데칸-2-온, 3-[N-[N-((R)-1-포스포노프로필)-(S)-류실]]-(-)-아미노-아자시클로트리데칸-2-온,N-[N-[N-(1-(R)-포스포노프로필)-(S)-류실]-O-메틸-(S)-티로신-(2-히드록시에틸)아미드, 3-[N-[N-((S)-포스포노프로필)-(S)-류실]]-(-)-아미노-아자시클로트리데칸-2-온, 모노에틸에스터, 나트륨 염 : 3-[N-[N-(1-프스포노프로필)-(S)-류실]]-(-)-아미노-아자시클로트리데칸-2-온, 이나트륨 염; 또는 3-[N-[N-(1-포스포노페틸)-(S)-류실]]-(-)-아미노-아자시클로트리데칸-2-온으로부터 선택한 화합물.
  9. 제1항 내지 제8항 중 어느 한 항에 있어서, 화합물의 제약학적으로 허용가능한 염, 용매화합물 또는 수화물.
  10. 하기 일반식(Ⅱ)의 화합물로부터 R20기를 분리시킴으로써 R20기를 수소로 전환시키고 필요하다면, R21을 수소로 전환시키는 것으로 구성되는 제1항의 일반식(Ⅰ)의 화합물의 제조방법.
    여기에서 R20은 알킬 또는 임의로 치환된 벤질이고 R21은 수소, 알킬 또는 임의로 치환된 벤질이고, R1,R2,R3및 R4는 제1항에서 일반식(Ⅰ)에 대해 정의한 바와 같다.
  11. 제10항에서 정의한 바와 같으나 단 R21이 수소가 아닌 일반식(Ⅱ)의 화합물.
  12. N-[N-[N-(1-디에톡시포스핀일에틸)-류실]-(S)-트립토필]-(S)알라닌, 메틸 에스터,N-[N-[N-(1-디에톡시포스핀일에틸)-류실]-O-메틸-(S)-티로실]-(S)-알라닌, 메틸에스터, 3-[N-[N-((S)-1-포스포노프로필)-(R)-류실]]-(-)-아미노-아자시클로트리데칸-2-온, 디에틸에스터, 3-[N-[N-((S)-1-포스포노프로필)-(S)-류실]]-(-)-아미노-아자시클로트리데칸-2-온, 디에틸 에스터, 3-[N-[N-(1-포스포노프로필)-(S)-류실]]-(-)-아미노-아자시클로트리데칸-2-온, 디벤질 에스터, N-[N-(1-(R)-포스포노프로필)-(S)-류실]-O-메틸-(S)-티로신-N-(2-히드록시에틸)아미드, 디벤질에스터, 또는 3-[N-[N-(1-포스포노펜틸)-(S)-류실]]-(-)-아미노-아자시클로트리데칸-2-온, 디벤질 에스터로부터 선택한 화합물.
  13. 제1항에서 정의한 바의 일반식(Ⅰ)의 화합물, 또는 그들의 제약학적으로 허용가능한 염, 용매화합물 또는 수화물, 및 제약학적으로 허용가능한 담체로 구성되는 제약학적 조성물.
  14. 활성적인 치료학적 물질 용도를 위한, 제1항에서 정의한 바의 일반식(Ⅰ)의 화합물, 또는 그들의 제약학적으로 허용 가능한 염, 용매화합물 또는 수화물.
  15. 결합조직 및 몸의 다른 단백질 성의 성분의 분해가 발생하는 증상의 치료 용도를 위한 제1항에서 정의한 바의 일반식(Ⅰ)의 화합물, 그들의 제약학적으로 허용가능한 염, 용매화합물 또는 그들의 수화물.
  16. 결합조직 및 몸의 다른 단백질 성분의 분해가 발생하는 증상의 치료용 약물 제조에 있어서 제1항에서 정의한 바의 일반식(Ⅰ)의 화합물, 또는 그들의 제약학적으로 허용 가능한 염, 용매화합물 또는 그들의 수화물의 용도.
    ※참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019900005135A 1989-04-13 1990-04-13 신규 화합물 KR900016238A (ko)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB89083589 1989-04-13
GB898908353A GB8908353D0 (en) 1989-04-13 1989-04-13 Novel compounds
GB898917756A GB8917756D0 (en) 1989-08-03 1989-08-03 Novel compounds
GB8917756.2 1989-08-03

Publications (1)

Publication Number Publication Date
KR900016238A true KR900016238A (ko) 1990-11-13

Family

ID=26295211

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019900005135A KR900016238A (ko) 1989-04-13 1990-04-13 신규 화합물

Country Status (7)

Country Link
EP (1) EP0401963A1 (ko)
JP (1) JPH0363294A (ko)
KR (1) KR900016238A (ko)
AU (1) AU618669B2 (ko)
CA (1) CA2014375A1 (ko)
NZ (1) NZ233288A (ko)
PT (1) PT93724A (ko)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8921326D0 (en) * 1989-09-21 1989-11-08 Beecham Group Plc Novel treatment
GB9008065D0 (en) * 1990-04-10 1990-06-06 Beecham Group Plc Novel compounds
EP0473936A1 (en) * 1990-09-04 1992-03-11 American Cyanamid Company Renin Inhibitors
US5189023A (en) * 1990-09-04 1993-02-23 American Cyanamid Company Renin inhibitors
GB9107368D0 (en) * 1991-04-08 1991-05-22 Smithkline Beecham Plc Novel compounds
US5155100A (en) * 1991-05-01 1992-10-13 Ciba-Geigy Corporation Phosphono/biaryl substituted dipeptide derivatives
US5294632A (en) * 1991-05-01 1994-03-15 Ciba-Geigy Corporation Phosphono/biaryl substituted dipetide derivatives
EP0520573A1 (en) * 1991-06-27 1992-12-30 Glaxo Inc. Cyclic imide derivatives
US5250522A (en) * 1992-10-09 1993-10-05 Ciba-Geigy Corporation Phosphono/biaryl substituted amino acid derivatives
GB9122859D0 (en) * 1991-10-28 1991-12-11 Smithkline Beecham Plc Novel compounds
JPH05148277A (ja) * 1991-11-05 1993-06-15 Banyu Pharmaceut Co Ltd アミノホスホン酸誘導体
WO1993021942A2 (en) * 1992-05-01 1993-11-11 British Biotech Pharmaceuticals Limited Use of mmp inhibitors
US5326760A (en) * 1992-06-29 1994-07-05 Glaxo, Inc. Aminobutanoic acid compounds having metalloprotease inhibiting properties
US5594106A (en) * 1993-08-23 1997-01-14 Immunex Corporation Inhibitors of TNF-α secretion
US5840698A (en) * 1994-10-27 1998-11-24 Affymax Technologies N.V. Inhibitors of collagenase-1 and stormelysin-I metalloproteases, pharmaceutical compositions comprising same and methods of their use
US5831004A (en) * 1994-10-27 1998-11-03 Affymax Technologies N.V. Inhibitors of metalloproteases, pharmaceutical compositions comprising same and methods of their use
IT1296305B1 (it) 1997-07-17 1999-06-25 Polifarma Spa Inibitori di metalloproteinasi loro uso terapeutico e procedimento per la produzione del composto di partenza nella loro

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CY1406A (en) * 1980-12-18 1988-04-22 Schering Corp Substituted dipeptides, processes for their preparation and pharmaceutical compositions containing them and their use in the inhibition of enkephalinase
US4558034A (en) * 1984-01-31 1985-12-10 The Board Of Trustees Of The University Of Kentucky Inhibitors of bacterial collagenase
GB8726714D0 (en) * 1987-11-14 1987-12-16 Beecham Group Plc Compounds

Also Published As

Publication number Publication date
CA2014375A1 (en) 1990-10-13
EP0401963A1 (en) 1990-12-12
JPH0363294A (ja) 1991-03-19
PT93724A (pt) 1990-11-20
NZ233288A (en) 1992-01-29
AU618669B2 (en) 1992-01-02
AU5315890A (en) 1990-10-18

Similar Documents

Publication Publication Date Title
KR900016238A (ko) 신규 화합물
KR890008155A (ko) 신규인 유도체, 그 제조방법 및 의약에서의 사용
DE69524609D1 (de) Verzoegerte freisetzung von peptiden aus pharmazeutischen zusammensetzungen
KR920021555A (ko) 비사이클릭 라파 마이신
KR890700601A (ko) 펩티딜아미노디올
HUP9701059A2 (hu) Stronciumsók alkalmazása ízületi bántalmak kezelésére alkalmas gyógyszerkészítmények előállítására
KR940003939A (ko) 이미다졸리딘 유도체
KR920021578A (ko) 포스프노/비아릴 치환된 디펩티드 유도체
KR890005147A (ko) 펩티딜헤테로사이클
DE69727956D1 (de) Pharmazeutische zubereitungen zur verminderung von atmungsdepressionen
EP0494071A3 (en) Trifluoromethylketone tripeptide derivatives
KR900003163A (ko) 시클로헥산 유도체
KR880011198A (ko) 사이클릭 펩타이드 및 이의 제조방법
EA199801028A1 (ru) Применение производных п-аминофенола для проготовления фармацевтических композиций, используемых при лечении нейродегенеративных заболеваний
HU9301520D0 (en) Methods for producing cyclopeptides promoting absorption of peptides and albumins through mucous membrane as well as pharmaceutical preparations containing said compounds as auxiliary agents
EA199700136A1 (ru) Способы ингибирования экзогенных эстрогенов
ES8303316A1 (es) Un procedimiento para la fabricacion de un disulfuro intra ointermolecular
AU2585188A (en) New N-(23-vinblastinoyl) derivatives of 1-aminomethyl- phosphonic acid, processes for preparing them and pharmaceutical compositions containing them
EA199800464A1 (ru) Синергическая иммуносупрессорная композиция, содержащая 2,2'-би-1н-пиррольное соединение
DE3474145D1 (en) Benzothiazolone derivatives, processes for preparation thereof and pharmaceutical compositions comprising the same
PT957920E (pt) Reducao dos efeitos toxicos de carboplatina utilizando ditioeteres
KR890003368A (ko) 특정의 치환된 페닐알킬아미노(및 아미노산) 유도체 및 기타 세로토닌농도 저하제로 오심 및 구토를 치료하는 방법
KR900017581A (ko) α-아미노보론산 유도체를 함유하는 펩티드-약제 조성물
NO981869D0 (no) Farmas÷ytiske preparater inneholdende blodplateaggregerings-inhibitorer
KR890007752A (ko) 빈크리스틴-함유 생성물

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid